Pfizer is developing a once-a-day weight-loss pill

Pfizer is developing a once-a-day weight-loss pill

/ 08:17 AM July 17, 2024

You can find several drugs that claim to help you achieve a slimmer figure, but they usually do not meet expectations.

Fortunately, it seems Pfizer is close to creating a truly effective weight-loss pill.

The Telegraph said the US pharmaceutical firm will start testing different doses of the experimental drug later this year. 

Article continues after this advertisement

READ: Vibrating pill tricks you into feeling full

FEATURED STORIES

Mikael Dolsten, Pfizer’s outgoing chief scientific officer and president of research and development, said it will “address the present and persistent medical needs of people living with obesity.”

More info on the weight-loss pill

The official Pfizer website calls its new weight-loss drug Danuglipron. The company designed it to be taken orally, but no health authorities have approved its use. 

Article continues after this advertisement

It is a type of investigational medicine known as a GLP-1 receptor agonist. In other words, it is a drug that maintains healthy blood sugar levels by increasing insulin production.

Article continues after this advertisement

Danuglipron also slows digestion and boosts the feeling of fullness after eating, which may help people lose weight.

Article continues after this advertisement

Nowadays, Pfizer is conducting a randomized study to test the drug’s safety and effectiveness. 

At the time of writing, the weight loss pill yielded promising results: Mikael Dolsten, MD., PhD., Chief Scientific Officer & President, Pfizer Research and Development, said the following regarding Danuglipron: 

Article continues after this advertisement

“Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates.”

“The most advanced of them, Danuglipron, has demonstrated good efficacy in a twice-daily formulation, and we believe a once-daily formulation has the potential to have a competitive profile in the oral GLP-1 space.” 

Until the weight-loss pill reaches pharmacy shelves, Ozempic will likely remain the popular choice.

The New York Times says it is diabetes medicine that the US Food and Drug Administration approved. 

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Eventually, the FDA approved a drug called Wegovy, which has a higher dose of Ozempic’s active ingredient. Wegovy started getting public attention when Elon Musk credited his new physique to it.

TOPICS: pharmaceutical, technology
TAGS: pharmaceutical, technology

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.